2016 Facility of the Year Awards Winners
ISPE Announces the 2016 Facility of the Year Awards Winners
ISPE’s Facility of the Year Awards honor the top pharmaceutical facilities for displaying innovation and creativity in manufacturing facilities serving the regulated healthcare industry. Congratulations to the nine 2016 Facility of the Year Awards winners:
|Baxter BioPharma Solutions
Baxter BioPharma Solutions has been recognized for the expansion of its parenteral manufacturing plant in Halle, Germany. The facility demonstrates operational excellence principals and innovative manufacturing concepts with state-of-the-art isolator technology, combined with high flexibility for rapid changeover and broad flexibility to manufacture a wide variety of liquid formulations.
Ethicon, LLC has been awarded for its facility in San Lorenzo, Puerto Rico. The site’s sustainability efforts resulted in energy reduction of 26% (4.4 million kWh), and water reduction of 9% (1.25 million gallons), while increasing production volume by 11%, compared to 2010 consumption levels.
|Genentech (a member of the Roche Group)
Genentech has been honored for its large-scale Cell Culture Biologics Drug Substance Plant 2 (CCP2). Located in Vacaville, California, this facility revamped an existing CCP2 Facility to support new process technology, which resulted in significant savings in capital ($50M).
|Janssen Vaccines AG
Janssen Vaccines AG is the recipient of this award for its “Fast Track Refurbishment for Ebola Vaccine Production” based in Bern, Switzerland. In response to the 2014 Ebola outbreak in West Africa, Janssen Vaccines AG accelerated the development of its candidate Ebola vaccine.
Pfizer Inc. has been recognized for its Portable, Continuous, Miniature and Modular (PCMM) prototype unit for Oral Solid Dosage forms, which transforms raw materials into uncoated tablets in minutes. The equipment fits into a portable facility called a POD that can be shipped to any location. The PCMM model increases project speed, enhances product quality, and reduces project cost.
|Takara Bio Inc.
Takara Bio Inc. has been awarded for its Center for Gene and Cell Processing (CGCP) in Shiga, Japan. In order to improve operational and cost efficiencies, Takara Bio Inc. housed cell products, viral vectors and recombinant proteins all within the same facility. To eliminate risk of cross contamination, Takara Bio Inc. integrated thorough facility and operational containment measures.
|Greater Pharma Co. Ltd
Greater Pharma has received honorable mention for its facility in Bangkok, Thailand. This facility is the first of its kind to apply western standards to design a pharmaceutical facility for tablets, capsules, sachets and liquids for the local ASEAN market.
|University of Strathclyde
University of Strathclyde has received honorable mention for its Centre for Continuous Manufacturing and Crystallisation (CMAC) in Glasgow, Scotland. The collaboration between industry, academia and government represents the future of pharmaceutical manufacturing and supply chain R&D framework.
|West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. has received honorable mention for its facility expansion in Kinston, North Carolina. West Pharmaceutical Services, Inc. is being recognized for its industry leading efforts to align primary components manufacturing process with current industry trends and standards.